BioLife Solutions, Inc.

NASDAQ:BLFS

Medical - Instruments & Supplies

Healthcare
$38.61 +1.56%

+$0.40 today

Market cap
$1.89B
Beta
1.97
P/E (TTM)
-119.9
EPS (TTM)
-$0.22
52W Low $17.86High $29.62

Volume 4.39M

Average 0.52M

BLFS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

BioLife Solutions, Inc.NASDAQ: BLFS

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 48.46M shares rose 2.8% year over year, in line with the +3.2% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.5% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.8% toward the trailing-twelve-month pace of +3.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
48.46M+1.5% QoQ
Last fiscal yearDec 2025
47.75M+3.7% YoY
LTMMar 2026
47.98M+3.2% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.8%——
1 year+3.7%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
47.75M USD
Year-over-year change
+3.7%
4-year CAGR
+5.5%

Weighted Avg Shares vs competitors

How BLFS compares with its peers on the latest reported figures

  • BLFS's LTM Mar 2026 weighted avg shares of 47.98M shares is the 8th highest of the 11 companies compared; the peer median is 50.45M shares.
  • Its year-over-year change of +3.2% is the 5th highest of 11, against a peer median of +2.4%.
  • Over three fiscal years its annual growth of +4.0% compares with a peer median of +4.4%.
BLFS Competitors Peer median
Weighted Avg Shares for BLFS and competitors
Company Period LTM YoY 3-year CAGR
NEOGNeogen CorporationLTM Aug 2026217.73M +0.3%+4.8%
NVCRNovoCure LimitedLTM Mar 2026112.28M +3.5%+2.1%
PLSEPulse Biosciences, Inc.LTM Jun 202667.94M +7.1%+25.7%
PHRPhreesia, Inc.LTM Apr 202659.86M +3.0%+4.4%
KMTSKestra Medical Technologies, Ltd.LTM Jan 202651.26M +3.5%—
STAASTAAR Surgical CompanyLTM Apr 202649.63M +0.8%+1.1%
ATRCAtriCure, Inc.LTM Jun 202648.12M +1.8%+1.4%
BLFSBioLife Solutions, Inc.LTM Mar 202647.98M +3.2%+4.0%
AZTAAzenta, Inc.LTM Sep 202645.14M -1.3%-12.0%
HROWHarrow Health, Inc.LTM Mar 202636.98M +3.5%+10.2%
ESTAEstablishment Labs Holdings Inc.LTM Sep 202629.95M +1.9%+6.6%
Peer median (excluding BLFS) 50.45M+2.4%+4.4%

Competitors are the stored peer set for BLFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue119.16M76.24M75.86M82.25M96.21M
Cost of Revenue90.31M29.33M96.52M28.58M34.1M
Gross Profit28.85M46.91M46.75M53.67M62.12M
Gross Margin24.2%61.5%61.6%65.3%64.6%
Research & Development11.82M14.8M18.8M7.91M7.57M
Selling, General & Admin48.09M44.93M55.97M50.15M55.37M
Operating Expenses73.34M52.83M117.58M60.8M74.25M
Depreciation & Amortization12.87M19.96M12.3M8.66M4.69M
EBITDA(16.65M)(124.18M)(45.24M)1.53M3.61M
EBITDA Margin-14.0%-162.9%-59.6%1.9%3.7%
Operating Income(35.16M)(5.92M)(23.44M)(7.13M)(1.08M)
Operating Margin-29.5%-7.8%-30.9%-8.7%-1.1%
Interest Income00000
Interest Expense485K687K1.81M719K2.71M
Other Income / Expenses6.13M1.08M4.97M(4.3M)(11M)
Income Before Tax(29.03M)(4.85M)(18.47M)(11.43M)(12.08M)
Pre-Tax Margin-24.4%-6.4%-24.4%-13.9%-12.6%
Income Tax Expense(20.12M)(5.24M)24K(38K)49K
Net Income(8.91M)(139.81M)(66.43M)(20.18M)(12.13M)
Net Margin-7.5%-183.4%-87.6%-24.5%-12.6%
EPS (Basic)(0.23)(3.29)(1.52)(0.44)(0.25)
EPS (Diluted)(0.23)(3.29)(1.52)(0.44)(0.25)
Weighted Avg Shares38.5M42.48M43.72M46.07M47.75M
Weighted Avg Shares (Diluted)38.5M42.48M43.72M46.07M48.65M

BioLife Solutions, Inc.

NASDAQ:BLFS

Intrinsic Alpha fair value

Locked

Current Price

$38.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.